2 months after Israel's vaccination campaign began, cases dropped by 77 per cent

Embargoed until: Publicly released: 2021-04-20 11:00

International

A significant drop in COVID-19 cases in Israel early this year was strongly influenced by the rollout of the Pfizer vaccine, according to Israeli researchers. By the end of February 2021, 85 per cent of people over 60 years old had received two doses of the vaccine, coinciding with a 77 per cent drop in cases and 68 per cent drop in hospitalisations from the peak of the virus in the country. Examining health data, the researchers found age groups prioritised for vaccination saw a greater decrease in COVID-19 cases and hospitalisations.

Media release

From:

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page

Journal/
conference: Nature Medicine

Research:Paper

Organisation/s: Weizmann Institute of Science, Israel

Funder: H.R. is supported by the Israeli Council for Higher Education via the Weizmann Data Science Research Center and by a research grant from Madame Olga Klein-Astrachan

Media Contact/s

Contact details are only visible to registered journalists.